MDA 19

1048973-47-2

CAS-Nr.: 1048973-47-2

Englisch Name:: MDA 19

Synonyma:: MDA 19;MDA19; MDA-19;N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide;(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide;N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide;N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide;Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide;MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide

CBNumber:: CB12535682

Summenformel:: C21H23N3O2

Molgewicht:: 349.43

MOL-Datei:: 1048973-47-2.mol

Eigenschaften Sicherheit Verwendungswort

MDA 19 Eigenschaften

Dichte: 1.16±0.1 g/cm3 (20 ºC 760 Torr)

storage temp.: Store at -20°C

Löslichkeit: DMF: 20 mg/ml; DMSO: 10 mg/ml; Ethanol: 3 mg/ml; Methanol: 1 mg/ml

Aggregatzustand: A crystalline solid

pka: 10.45±0.20(Predicted)

Farbe: Light yellow to yellow

Sicherheit

MDA 19 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

MDA 19 is a selective agonist of the human peripheral cannabinoid (CB2) receptor. A cell-based functional assay showed MDA is an inverse agonist of the CB2 receptor in rat. Acts as an inverse agonist at the rat CB2 receptor. Reported Ki values are 16.3 and 1130 nM for human CB2 and CB1 receptor respectively. MDA19 was effective in attenuating tactile allodynia in neuropathic rats. MDA19 thus has potential for alleviating neuropathic pain without producing adverse effects in the central nervous system.Synthetic Cannabinoids

MDA 19 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1048973-47-2()Verwandte Suche:

2,6-Dihydroxybenzoesure p-(Methylsulfonyl)benzoesure 3,5-Dihydroxybenzoesure

(Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide
N'-(1-Hexyl-2-oxoindolin-3-ylidene)benzohydrazide
MDA 19 (Z)-N'-(1-hexyl-2-oxoindolin-3-ylidene)benzohydrazide
MDA 19
N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide
Benzoic acid (2Z)-2-(1-hexyl-1,2-dihydro-2-oxo-3H-indol-3-ylidene)hydrazide
N-[(Z)-(1-Hexyl-2-oxo-indolin-3-ylidene)aMino]benzaMide
MDA19; MDA-19
1048973-47-2